The Gut Microbiome of Non-Atopic Chronic Hand Eczema (CHE) Subjects is Distinct and Enriched in Immuno-Modulatory Bacteria Species compared to Atopic-CHE and Healthy Subjects
Authors: Bissonnette R, Salem Y, Palijan A, Maari C, Proulx ES, Prifti DK, Hunter S, Routy B,Elkrief A. Read more on pubmed
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
Authors: Bissonnette R, Albreiki F, Ehst BD, Al Hammadi A, Schliemann S, Yang B, Zhang J, BunickCG. Read more on pubmed
Dupilumab Treatment Up to 5 Years Shows No Clinically Meaningful Changes in Laboratory Parameters in Adults with Moderate-to-Severe Atopic Dermatitis
Authors: Simpson EL, Bissonnette R, Deleuran M, Nakahara T, Galus R, de Bruin-Weller M, Coleman A, van Spall M, Chen Z, Avetisova E, Bastian M, Khokhar FA. Read more on pubmed
Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis
Authors: David Strawn, James G Krueger, Robert Bissonnette, Kilian Eyerich, Laura K Ferris, Amy S Paller, Andreas Pinter, Dylan Richards, Elizabeth Y Chen, Kate Paget, Daniel Horowitz, Roohid Parast, Joshua J Rusbuldt, Jocelyn Sendecki, Sunita Bhagat, Lynn P Tomsho, Ching-Heng Chou, Marta E Polak, Brice E Keyes, Emily Bozenhardt, Yuan Xiong, Wangda Zhou, Cynthia DeKlotz, […]
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
Authors: Gooderham M, Lain E, Bissonnette R, Huang YH, Lynde CW, Hoffmann M, Song EJ, Weirich O, Ceitlin RHG, Rubens JH, Delozier AM, Ota T, Hsu M-C, Li S, DeKlotz CMC, Nunes F, Warren RB Read more on pubmed
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
Authors: Guttman-Yassky E, Kabashima K, Worm M, Luna PC, Hong CHH, Chovatiya R, Berstein JA, Kern JS, Ehst BD, Magnolo N, Herranz-Pinto P, Stein Gold L, Sofen H, Pink AE, Esfandiari E, Arai T, Shi R, Barragan C, Kricorian G, Schwartz-Sagi L, Bissonnette R Read more on pubmed
Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers
Authors: Bissonnette R, Saint-Cyr Proulx, E, Correa da Rosa J, Estrada Y, Ren H, Nawaz H, Halden P, Stefani-Hunyady D, Popovic K, Volkova A, Smith SH, Guttman-Yassky E Read more on pubmed
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigo
Authors: Stahl LS, Zeidler C, Loewenthal J, Royeck S, Augustin M, Bissonnette R, Elmariah S, Kim BS, Misery L, Murota H, Liang Tey H, Weisshaar E, Yosipovitch G, Legat FJ, Reich A, Metz M, Stander S Read more on pubmed
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
Authors: Bissonnette R, Soung J, Hebert AA, Pink AE, Pinter A, Moor AY, Shi Y, Wang W-H, Toth DP, Miller-Kassamali M, Cafone J, Jiang J, Li S, DeKlotz CMC, Nunes F, Lebwohl MG Read more on pubmed
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, DoubleâBlind, Phase 3 Trials
Authors: Bissonnette R, Albreiki F, Ehst BD, Hammadi AA, Schliemann S, Yang B, Zhang J, Bunick CG Read more on pubmed
